Table 3.
Remission Rates of Antidepressants in Subgroups of Female Teenagers
| Strata for Female Teenagers | Bupropion | Citalopram | Escitalopram | Fluoxetine | Sertraline |
|---|---|---|---|---|---|
| Ignoring predictors of remission | 43.15% | 11.78% | 34.07% | 41.43% | |
| Other Malaise & Fatigue | 5.21% | 13.56% | 38.74% | 52.59% | |
| Anxiety State, Unspecified | 4.72% | 11.93% | 31.07% | 50.93% | |
| History of use of Escitalopram Oxalate | Last Antidepressant Different & No Remission | 3.00% | 47.62% | 33.45% | 37.37% | |
| History of use of Citalopram Hydrobromide | 4.75% | 34.02% | 13.93% | 23.39% | 27.27% |
| History of use of Escitalopram Oxalate | 3.53% | 40.04% | 18.21% | 22.46% | 25.18% |
| Insomnia, Unspecified | 36.15% | 43.36% | |||
| History of use of Amitriptyline HCL | 6.42% | 27.03% | 10.87% | 23.49% | 27.66% |
| Routine Infant or Child Health Check | 32.92% | 31.46% | 38.11% | ||
| Headache | 3.74% | 31.90% | 41.03% | ||
| History of use of Sertraline HCL | 3.81% | 24.03% | 12.76% | 24.31% | 34.13% |
| Depressive Disorder, Not Elsewhere Classified | 2.72% | 33.49% | 13.31% | 31.68% | 41.80% |
| Abnormal Weight Gain | 3.57% | 41.99% | |||
| History of use of Bupropion HCL | Last Antidepressant Different & No Remission | 15.54% | 42.73% | |||
| Routine Gynecological Examination | 15.02% | 38.95% | |||
| History of use of Citalopram Hydrobromide | Last Antidepressant Different & No Remission | 2.83% | 15.68% | 34.13% | 35.78% | |
| History of use of Amitriptyline HCL | History of use of Fluoxetine HCL | 37.00% | ||||
| Last Antidepressant Different & No Remission | History of use of Sertraline HCL | 2.96% | 23.71% | 10.89% | 33.42% | |
| Major Depressive Disorder, Recurrent Episode, Unspecified | 37.03% | 62.14% | 41.62% | 44.22% | 50.71% |
| Last Antidepressant Different & No Remission| History of use of Paroxetine HCL | 4.88% | 11.57% | 39.66% | ||
| Myopia | 5.68% | 35.60% | 15.61% | 40.44% | 40.33% |
| History of use of Fluoxetine HCL | 5.86% | 23.68% | 11.50% | 30.42% | 24.91% |
| History of use of Citalopram Hydrobromide | Psychotherapy, 45 Minutes with Patient | 43.45% | 15.57% | 14.56% | ||
| History of use of Amitriptyline HCL | History of use of Sertraline HCL | 36.39% | ||||
| History of use of Dextroamphetamine/Amphetamine | 9.04% | 28.70% | 43.03% | ||
| Adjustment Disorder with Mixed Anxiety & Depressed Mood | 2.42% | 13.18% | 36.21% | ||
| History of use of Fluoxetine HCL | Last Antidepressant Different & No Remission | 3.49% | 33.61% | 11.55% | 35.37% | |
| Routine General Medical Examination at Health Care Facility | 10.53% | 42.99% | |||
| Last Antidepressant Different & No Remission | History of use of Sertraline HCL | 12.68% | 27.45% | 43.75% | ||
| History of use of Ethinyl Estradiol/Drospirenone | 34.29% | 13.45% | 43.72% |
Cell entries are remission rates for the antidepressant for a female teenager in the strata. Bold entries show antidepressants with highest remission rate. The complete data for all age, gender, and medical history strata in the online supplement.